Is AN2 Therapeutics, Inc. technically bullish or bearish?
As of September 11, 2025, AN2 Therapeutics, Inc. shows a neutral trend with mixed indicators, mildly bullish on weekly MACD and KST but bearish on daily moving averages, while outperforming the S&P 500 recently but having a negative year-to-date return, suggesting a cautious investment approach.
As of 11 September 2025, the technical trend for AN2 Therapeutics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD and KST are mildly bullish, while the daily moving averages are mildly bearish. The Bollinger Bands show a bullish signal on the weekly timeframe but a mildly bearish signal on the monthly. The Dow Theory indicates a mildly bullish trend on both weekly and monthly timeframes. In terms of performance, AN2 Therapeutics has outperformed the S&P 500 over the past week and month, with returns of 1.57% and 15.18%, respectively, compared to 1.05% and 2.33% for the index. However, the year-to-date return is negative at -6.52%, contrasting with the S&P 500's positive return of 12.22%. Overall, the mixed signals suggest a cautious approach.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
